CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
出版年份 2012 全文链接
标题
CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
作者
关键词
Pancreatic Cancer, Chronic Pancreatitis, Pancreatic Adenocarcinoma, Chronic Pancreatitis Patient, Pancreatic Head Carcinoma
出版物
ANNALS OF SURGICAL ONCOLOGY
Volume 20, Issue 7, Pages 2188-2196
出版商
Springer Nature
发表日期
2012-12-17
DOI
10.1245/s10434-012-2809-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The prognostic and predictive value of serum CA19.9 in pancreatic cancer
- (2012) J. L. Humphris et al. ANNALS OF ONCOLOGY
- Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial
- (2012) Michele Reni et al. ANNALS OF SURGICAL ONCOLOGY
- A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
- (2012) Peter J Hosein et al. BMC CANCER
- Arterial Resection During Pancreatectomy for Pancreatic Cancer
- (2011) Nathan Mollberg et al. ANNALS OF SURGERY
- Pancreatic Cancer Surgery in the New Millennium
- (2011) Werner Hartwig et al. ANNALS OF SURGERY
- Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial
- (2011) William F. Regine et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
- (2011) Shojiro Hata et al. ANNALS OF SURGICAL ONCOLOGY
- Major Molecular Markers in Pancreatic Ductal Adenocarcinoma and Their Roles in Screening, Diagnosis, Prognosis, and Treatment
- (2011) Puneet Singh et al. PANCREAS
- Serum CA19–9 Alterations During Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Invasive Ductal Carcinoma of the Pancreas as an Indicator for Therapeutic Selection and Survival
- (2010) Hidenori Takahashi et al. ANNALS OF SURGERY
- Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
- (2010) Philip Q. Bao et al. ANNALS OF SURGICAL ONCOLOGY
- Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease
- (2010) Sherif R. Z. Abdel-Misih et al. ANNALS OF SURGICAL ONCOLOGY
- Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
- (2010) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
- (2010) Naru Kondo et al. ANNALS OF SURGICAL ONCOLOGY
- Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy
- (2010) J Bernhard et al. BRITISH JOURNAL OF CANCER
- Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer
- (2010) Gilda da Cunha Santos et al. CANCER
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multivisceral Resection for Pancreatic Malignancies
- (2009) Werner Hartwig et al. ANNALS OF SURGERY
- Resectable Pancreatic Cancer: Who Really Benefits From Resection?
- (2009) Giuliano Barugola et al. ANNALS OF SURGICAL ONCOLOGY
- CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone
- (2009) H S Wasan et al. BRITISH JOURNAL OF CANCER
- Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma
- (2009) Michele Reni et al. CANCER
- Very High Serum CA 19-9 Levels: A Contraindication to Pancreaticoduodenectomy?
- (2009) O. Turrini et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
- (2009) Joshua G. Barton et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma
- (2008) Shishir K. Maithel et al. ANNALS OF SURGICAL ONCOLOGY
- Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704
- (2008) Adam C. Berger et al. JOURNAL OF CLINICAL ONCOLOGY
- CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
- (2008) Viviane Hess et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started